CELLECTAR TARGETS MID-2027 ACCELERATED APPROVAL NDA FOR IOPOFOSINE IN WM, BACKED BY UP TO $140M FINANCING - SEEKINGALPHA

Mid-2027 NDA target plus $140M financing signals near-term regulatory catalyst.